Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Hodgkin's or Non-Hodgkin's Lymphoma

Key facts

Sponsor

Children's Oncology Group

Principal Investigator

Richard E. Harris, MD

Children's Hospital Medical Center, Cincinnati

Intervention

carmustine(drug)

Enrollment

69 enrolled

Eligibility

1-21 years · All sexes

Timeline

1998 – 2007

Study locations (30)

• University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States
• University of South Alabama Medical Center, Mobile, Alabama, United States
• Phoenix Children's Hospital, Phoenix, Arizona, United States
• Arizona Cancer Center, Tucson, Arizona, United States
• University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
• Southern California Permanente Medical Group, Downey, California, United States
• City of Hope Comprehensive Cancer Center, Duarte, California, United States
• Rebecca and John Moores UCSD Cancer Center, La Jolla, California, United States
• Loma Linda University Medical Center, Loma Linda, California, United States
• Jonathan Jaques Children's Cancer Center, Long Beach, California, United States
• Children's Hospital Los Angeles, Los Angeles, California, United States
• Cedars-Sinai Medical Center, Los Angeles, California, United States
• Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
• Children's Hospital Central California, Madera, California, United States
• Children's Hospital of Oakland, Oakland, California, United States
• +15 more locations on ClinicalTrials.gov

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT05621291
  A Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymphoblastic Leu...
  National Cancer Institute (NCI)
• RECRUITINGPHASE2NCT07328503
  CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
  National Cancer Institute (NCI)
• ENROLLING BY INVITATIONNCT07511959
  Autologous Exosomes From Platelet-rich Plasma as a Modern Tool of Regenerative Dentistry
  Wroclaw Medical University
• RECRUITINGPHASE2NCT06738368
  Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia
  University of Washington
• RECRUITINGNANCT07191119
  Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia
  St. Jude Children's Research Hospital
• RECRUITINGPHASE2NCT07275762
  Y-4 to Treat the Postherpetic Neuralgia
  Neurodawn Pharmaceutical Co., Ltd.
• RECRUITINGNANCT07177183
  Low Serum Creatinine as a Predictor of Prolonged Mechanical Ventilation and Weaning Failure
  University Hospital Ostrava
• RECRUITINGNANCT07201974
  Virtual Reality for Post-Stroke Gait Rehabilitation
  McGill University

See all trials for Acute lymphoblastic leukemia →